Journal of Pathology and Translational Medicine

Review

Cytology Specimen Management, Triage and Standardized Reporting of Fine Needle Aspiration Biopsies of the Pancreas: Won Jae Yoon, Martha Bishop Pitman; J Pathol Transl Med. 2015;49(5):364-372. Published online August 10, 2015; DOI: https://doi.org/10.4132/jptm.2015.07.19

12,009 View
131 Download
6 Web of Science
7 Crossref

The recent advances in pancreas cytology specimen sampling methods have enabled a specific cytologic diagnosis in most cases. Proper triage and processing of the cytologic specimen is pivotal in making a diagnosis due to the need for ancillary testing in addition to cytological evaluation, which is especially true in the diagnosis of pancreatic cysts. Newly proposed terminology for pancreaticobiliary cytology offers a standardized language for reporting that aims to improve communication among patient caregivers and provide for increased flexibility in patient management. This review focuses on these updates in pancreas cytology for the optimal evaluation of solid and cystic lesions of the pancreas.

Citations

Citations to this article as recorded by

“Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience With 1290 Resections”
Jorge Roldán, Jon M. Harrison, Motaz Qadan, Louisa Bolm, Taisuke Baba, William R. Brugge, Brenna W. Casey, Kumar Krishnan, Mari Mino-Kenudson, Martha B. Pitman, Avinash Kambadakone, Cristina R. Ferrone, Andrew L. Warshaw, Keith D. Lillemoe, Carlos Fernánd
Annals of Surgery.2023; 277(3): 491. CrossRef
Role of fluorescence confocal microscopy for rapid evaluation of EUS fine-needle biopsy sampling in pancreatic solid lesions
Serena Stigliano, Anna Crescenzi, Chiara Taffon, Francesco Covotta, Cesare Hassan, Giulio Antonelli, Martina Verri, Dario Biasutto, Roberto Mario Scarpa, Francesco Maria Di Matteo
Gastrointestinal Endoscopy.2021; 94(3): 562. CrossRef
Towards optimal pancreatic cyst fluid management: the need for standardisation
Giacomo Puppa, Yann Christinat, Thomas Alexander McKee
Gut.2019; 68(10): 1906. CrossRef
It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer
Jong-chan Lee, Haeryoung Kim, Hyoung Woo Kim, Jongchan Lee, Kyu-hyun Paik, Jingu Kang, Jin-Hyeok Hwang, Jaihwan Kim
Hepatobiliary & Pancreatic Diseases International.2018; 17(6): 553. CrossRef
Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer
Milosz Wiktorowicz, Damian Mlynarski, Radoslaw Pach, Romana Tomaszewska, Jan Kulig, Piotr Richter, Marek Sierzega
Pancreatology.2018; 18(8): 977. CrossRef
Variations in cancer centers’ use of cytology for the diagnosis of unresectable pancreatic cancer in the National Cancer Data Base
Ted Gansler, Stacey A. Fedewa, Chun Chieh Lin, Ahmedin Jemal, Elizabeth M. Ward
Cancer Cytopathology.2016; 124(11): 791. CrossRef
Pancreatic Cytopathology
Jennifer A. Collins, Syed Z. Ali, Christopher J. VandenBussche
Surgical Pathology Clinics.2016; 9(4): 661. CrossRef

Original Article

Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience: Ji Hye Park, Sun Och Yoon, Eun Ju Son, Hye Min Kim, Ji Hae Nahm, SoonWon Hong; Korean J Pathol. 2014;48(2):133-139. Published online April 28, 2014; DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.2.133

9,976 View
62 Download
36 Crossref

Abstract PDF

Background

The Bethesda System for Reporting Thyroid Cytopathology (BSRTC) uses six diagnostic categories to standardize communication of thyroid fine-needle aspiration (FNA) interpretations between clinicians and cytopathologists. Since several studies have questioned the diagnostic accuracy of this system, we examined its accuracy in our hospital.

Methods

We calculated the incidences and malignancy rates of each diagnostic category in the BSRTC for 1,730 FNAs that were interpreted by four cytopathologists in Gangnam Severance Hospital between October 1, 2011, and December 31, 2011.

Results

The diagnostic incidences of categories I-VI were as follows: 13.3%, 40.6%, 9.1%, 0.4%, 19.3%, and 17.3%, respectively. Similarly, the malignancy rates of these categories were as follows: 35.3%, 5.6%, 69.0%, 50.0%, 98.7%, and 98.9%, respectively. In categories II, V, and VI, there were no statistically significant differences in the ranges of the malignancy rates among the four cytopathologists. However, there were significant differences in the ranges for categories I and III.

Conclusions

Our findings suggest that institutions that use the BSRTC should regularly update their diagnostic criteria. We also propose that institutions issue an annual report of incidences and malignancy rates to help other clinicians improve the case management of patients with thyroid nodules.

Citations

Citations to this article as recorded by

A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More
Merve Bagıs, Nuray Can, Necdet Sut, Ebru Tastekin, Ezgi Genc Erdogan, Buket Yilmaz Bulbul, Yavuz Atakan Sezer, Osman Kula, Elif Mercan Demirtas, Inci Usta
Endocrine Pathology.2024; 35(1): 51. CrossRef
A COMPARATIVE STUDY BETWEEN CONVENTIONAL METHOD AND THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY
Pooja Mangal, Arti Gupta
GLOBAL JOURNAL FOR RESEARCH ANALYSIS.2023; : 67. CrossRef
Study of Fine Needle Aspiration Cytology (FNAC) of Thyroid Gland According to the Bethesda System
Keval A Patel, Garima Anandani, Bhawana S Sharma, Riddhi A Parmar
Cureus.2023;[Epub] CrossRef
Correlation of Thyroid Fine Needle Aspiration Biopsy With Histopathological Results
Cemalettin Durgun
Cureus.2023;[Epub] CrossRef
The Bethesda System for Reporting Thyroid Cytopathology: Validating at Tribhuvan University Teaching Hospital
Kunjan Acharya, Shreya Shrivastav, Prashant Triipathi, Bigyan Raj Gyawali, Bijaya Kharel, Dharma Kanta Baskota, Pallavi Sinha
International Archives of Otorhinolaryngology.2022; 26(01): e097. CrossRef
Validating the ‘CUT score’ risk stratification tool for indeterminate thyroid nodules using the Bethesda system for reporting thyroid cytopathology
Sapir Pinhas, Idit Tessler, Luba Pasherstnik Bizer, Khaled khalilia, Meir Warman, Meital Adi, Doron Halperin, Oded Cohen
European Archives of Oto-Rhino-Laryngology.2022; 279(1): 383. CrossRef
ANALYSIS OF FINE NEEDLE ASPIRATIONS OF THE THYROID: CYTOLOGICAL-HISTOPATHOLOGICAL CORRELATION AND OUTCOMES OF THE BETHESDA SYSTEM
Ayca TAN
SDÜ Tıp Fakültesi Dergisi.2022; 29(2): 213. CrossRef
Reproducibility of cytomorphological diagnosis and assessment of risk of malignancy of thyroid nodules based on the bethesda system for reporting thyroid cytopathology: A tertiary cancer center perspective
Sasmita Panda, Mamita Nayak, Lucy Pattanayak, PareshKumar Behera, Sagarika Samantaray, Sashibhusan Dash
Journal of Microscopy and Ultrastructure.2022; 10(4): 174. CrossRef
Comparative analysis of cytomorphology of thyroid lesion on conventional cytology versus liquid-based cytology and categorize the lesions according to The Bethesda System for Reporting Thyroid Cytopathology
MQamar Alam, Pinki Pandey, Megha Ralli, JitendraPratap Singh Chauhan, Roopak Aggarwal, Vineet Chaturvedi, Asttha Kapoor, Kapil Trivedi, Savita Agarwal
Journal of Cancer Research and Therapeutics.2022; 18(9): 259. CrossRef
Thyroid cytology in Pakistan: An institutional audit of the atypia of undetermined significance/follicular lesion of undetermined significance category
Saira Fatima, Rabia Qureshi, Sumbul Imran, Romana Idrees, Zubair Ahmad, Naila Kayani, Arsalan Ahmed
Cytopathology.2021; 32(2): 205. CrossRef
Outcomes of the Bethesda system for reporting thyroid cytopathology: Real‐life experience
Galit Avior, Or Dagan, Isaac Shochat, Yulia Frenkel, Idit Tessler, Alona Meir, Anat Jaffe, Oded Cohen
Clinical Endocrinology.2021; 94(3): 521. CrossRef
National differences in cost analysis of Afirma Genomic sequencing classifier
Ohad Ronen, Maya Oichman
Clinical Endocrinology.2021; 94(4): 717. CrossRef
Thyroid malignancy rates according to the Bethesda reporting system in Israel - A multicenter study
Ory Madgar, Galit Avior, Isaac Shochat, Ben-Zion Joshua, Lior Baraf, Yuval Avidor, Avi khafif, Niddal Assadi, Eran E. Alon
European Journal of Surgical Oncology.2021; 47(6): 1370. CrossRef
Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population
Sonam Choden, Chimi Wangmo, Sushna Maharjan
Diagnostic Cytopathology.2021; 49(11): 1179. CrossRef
Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
Adnan Zahid, Waqas Shafiq, Khawaja Shehryar Nasir, Asif Loya, Syed Abbas Raza, Sara Sohail, Umal Azmat
Journal of Clinical & Translational Endocrinology.2021; 23: 100250. CrossRef
The combination of ACR‐Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules—An institutional experience
Shanmugasundaram Sakthisankari, Sreenivasan Vidhyalakshmi, Sivanandam Shanthakumari, Balalakshmoji Devanand, Udayasankar Nagul
Cytopathology.2021; 32(4): 472. CrossRef
Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison
Suhail Al-Salam, Charu Sharma, Maysam T. Abu Sa’a, Bachar Afandi, Khaled M. Aldahmani, Alia Al Dhaheri, Hayat Yahya, Duha Al Naqbi, Esraa Al Zuraiqi, Baraa Kamal Mohamed, Shamsa Ahmed Almansoori, Meera Al Zaabi, Aysha Al Derei, Amal Al Shamsi, Juma Al Kaa
PLOS ONE.2021; 16(4): e0247807. CrossRef
Incidence, Clinical Characteristics, and Histopathological Results of Atypia of Undermined Significance in a Tertiary Center in UAE
Maha Osman Shangab, Azza Abdulaziz Khalifa, Fatheya Al Awadi, Mouza Alsharhan, Alaaeldin Bashier
Dubai Diabetes and Endocrinology Journal.2021; 27(1): 1. CrossRef
McGill Thyroid Nodule Score in Differentiating Thyroid Nodules in Total Thyroidectomy Cases of Indeterminate Nodules
Hadi A Al-Hakami, Reem Al-Mohammadi, Rami Al-Mutairi, Haya Al-Subaie, Mohammed A Al Garni
Indian Journal of Surgical Oncology.2020; 11(2): 268. CrossRef
The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
Bakiarathana Anand, Anita Ramdas, Marie Moses Ambroise, Nirmal P. Kumar
Journal of Thyroid Research.2020; 2020: 1. CrossRef
Differences in cytopathologist thyroid nodule malignancy rate
Ohad Ronen, Hector Cohen, Eyal Sela, Mor Abu
Cytopathology.2020; 31(4): 315. CrossRef
Thyroid Multimodal Ultrasound Evaluation—Impact on Presurgical Diagnosis of Intermediate Cytology Cases
Andreea Borlea, Dana Stoian, Laura Cotoi, Ioan Sporea, Fulger Lazar, Ioana Mozos
Applied Sciences.2020; 10(10): 3439. CrossRef
Fine-needle aspiration cytology of nodular thyroid lesions: A 1-year experience of the thyroid cytopathology in a large regional and a University Hospital, with histological correlation
Kaumudi Konkay, Radhika Kottu, Mutheeswaraiah Yootla, Narendra Hulikal
Thyroid Research and Practice.2019; 16(2): 60. CrossRef
Review of a single institution's fine needle aspiration results for thyroid nodules: Initial observations and lessons for the future
Ohad Ronen, Hector Cohen, Mor Abu
Cytopathology.2019; 30(5): 468. CrossRef
Strain Elastography as a Valuable Diagnosis Tool in Intermediate Cytology (Bethesda III) Thyroid Nodules
Dana Stoian, Florin Borcan, Izabella Petre, Ioana Mozos, Flore Varcus, Viviana Ivan, Andreea Cioca, Adrian Apostol, Cristina Adriana Dehelean
Diagnostics.2019; 9(3): 119. CrossRef
Improvement of diagnostic performance of pathologists by reducing the number of pathologists responsible for thyroid fine needle aspiration cytology: An institutional experience
Jae Yeon Seok, Jungsuk An, Hyun Yee Cho
Diagnostic Cytopathology.2018; 46(7): 561. CrossRef
Bethesda Classification and Cytohistological Correlation of Thyroid Nodules in a Brazilian Thyroid Disease Center
Kassia B. Reuters, Maria C.O.C. Mamone, Elsa S. Ikejiri, Cleber P. Camacho, Claudia C.D. Nakabashi, Carolina C.P.S. Janovsky, Ji H. Yang, Danielle M. Andreoni, Rosalia Padovani, Rui M.B. Maciel, Felipe A.B. Vanderlei, Rosa P.M. Biscolla
European Thyroid Journal.2018; 7(3): 133. CrossRef
The impact of rapid on‐site evaluation on thyroid fine‐needle aspiration biopsy: A 2‐year cancer center institutional experience
Ricardo G. Pastorello, Camila Destefani, Pedro H. Pinto, Caroline H. Credidio, Rafael X. Reis, Thiago de A. Rodrigues, Maryane C. de Toledo, Louise De Brot, Felipe de A. Costa, Antonio G. do Nascimento, Clóvis A. L. Pinto, Mauro A. Saieg
Cancer Cytopathology.2018; 126(10): 846. CrossRef
The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists
Mimi Kim, Hyo Jin Park, Hye Sook Min, Hyeong Ju Kwon, Chan Kwon Jung, Seoung Wan Chae, Hyun Ju Yoo, Yoo Duk Choi, Mi Ja Lee, Jeong Ja Kwak, Dong Eun Song, Dong Hoon Kim, Hye Kyung Lee, Ji Yeon Kim, Sook Hee Hong, Jang Sihn Sohn, Hyun Seung Lee, So Yeon Pa
Journal of Pathology and Translational Medicine.2017; 51(4): 410. CrossRef
Thyroid FNA cytology in Asian practice—Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas
K. Kakudo, M. Higuchi, M. Hirokawa, S. Satoh, C. K. Jung, A. Bychkov
Cytopathology.2017; 28(6): 455. CrossRef
Thyroid Fine-Needle Aspiration Cytology Practice in Korea
Yoon Jin Cha, Ju Yeon Pyo, SoonWon Hong, Jae Yeon Seok, Kyung-Ju Kim, Jee-Young Han, Jeong Mo Bae, Hyeong Ju Kwon, Yeejeong Kim, Kyueng-Whan Min, Soonae Oak, Sunhee Chang
Journal of Pathology and Translational Medicine.2017; 51(6): 521. CrossRef
Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia
Mohamed Abdulaziz Al Dawish, Asirvatham Alwin Robert, Aljuboury Muna, Alkharashi Eyad, Abdullah Al Ghamdi, Khalid Al Hajeri, Mohammed A Thabet, Rim Braham
World Journal of Clinical Oncology.2017; 8(2): 151. CrossRef
A meta‐analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Patrizia Straccia, Esther Diana Rossi, Tommaso Bizzarro, Chiara Brunelli, Federica Cianfrini, Domenico Damiani, Guido Fadda
Cancer Cytopathology.2015; 123(12): 713. CrossRef
Value of TIRADS, BSRTC and FNA-BRAFV600E mutation analysis in differentiating high-risk thyroid nodules
Yu-zhi Zhang, Ting Xu, Dai Cui, Xiao Li, Qing Yao, Hai-yan Gong, Xiao-yun Liu, Huan-huan Chen, Lin Jiang, Xin-hua Ye, Zhi-hong Zhang, Mei-ping Shen, Yu Duan, Tao Yang, Xiao-hong Wu
Scientific Reports.2015;[Epub] CrossRef
A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
P. Arul, C. Akshatha, Suresh Masilamani
Biomedical Journal.2015; 38(6): 517. CrossRef
Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective
Samreen Naz, Atif Hashmi, Amna khurshid, Naveen Faridi, Muhammad Edhi, Anwar Kamal, Mehmood Khan
International Archives of Medicine.2014; 7(1): 46. CrossRef

Editorial

Why and How to Use Surgical Pathology Terminology in Korean?.: Je G Chi; Korean J Pathol. 2005;39(6):442-444.

1,562 View
17 Download

Abstract PDF: The great majority of the terms that are used in describing the pathological findings are in English. These English terms became very familiar to most surgical pathologists in non-English speaking countries including Korea. Considering the situation of global importance of diagnostic pathology for the better international communication. It is acceptable to our Korean pathologists to be competent in English and English terminology. However, it is equally important to be competent and fluent in Korean terminology as well. Therefore, instead of mixing or combining two languages in describing pathological changes, it should be encouraged to be competent in both Korea and English. The author proposes a list of Korean terms that could best fit for the corresponding English terms that are frequently used in describing gross and microscopic findings in routine surgical pathology. It is hoped that these proposed terms could be standardized through the process of feedback from the members of our Society, and be used routinely in everyday practice.

First
Prev
Page of 1
Next
Last

Search